MARSHALL HULETT: Open Payments
NPI 1932898210 · BAXLEY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $62 |
| Lilly USA, LLC | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Amgen Inc. | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, GVOKE HYPOPEN, AIRSUPRA, KRYSTEXXA, MOUNJARO, ELIQUIS, XYOSTED, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
